1,095
Participants
Start Date
June 20, 2022
Primary Completion Date
August 31, 2022
Study Completion Date
August 31, 2023
Serological field test for HAT
Whole blood is tested by lateral flow or agglutination (CATT) for the presence of trypanosome specific antibody. Participants testing positive for at least one of these tests will undergo microscopic examination to detect trypanosomes (lymph, mAECT on blood) and DBS will be prepared for immunological and molecular laboratory testing.
malaria rapid test
RDT detecting HRP2 plasmodium antigen.
Immunologic laboratory tests
Laboratory tests detecting trypanosoma brucei gambiense specific (VSG) antibodies in DBS. These tests will only be carried out on participants that are positive in at least on of the rapid serological tests
Molecular laboratory tests
Laboratory tests detecting Trypanozoon specific nucleic acids. These tests will only be carried out on participants that are positive in at least on of the rapid serological tests
Université Jean Lorougnon Guédé de Daloa, Bonon
Programme Nationale de Lutte contre la Trypanosomiase Humaine Africaine, Ministère de Santé, Division Prévention et Lutte contre la Maladie, Dubréka
Foundation for Innovative New Diagnostics
UNKNOWN
Programme National de lutte contre la THA, Guinée
UNKNOWN
Université Jean Lorougnon Guédé, Daloa
UNKNOWN
Institut Pasteur, Guinée
UNKNOWN
Institut Pierre Richet, Guinée
UNKNOWN
Institut de Recherche pour le Developpement
OTHER_GOV